Clinical Trial

Laparoendoscopic Rendezvous for Concomitant Gall Bladder Stones and Common Bile Duct Stones

Study acronym: LERV
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 19, 2025 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Chronic calculous cholecystitis in pediatric patients leads to choledocholithiasis in about 12% of cases. These patients require removal of stones from the common bile duct. The most common method of cleaning the common bile duct is endoscopic retrograde cholangiopancreatography, and the standard technique for removing the gallbladder is laparoscopic cholecystectomy. There are different approaches to the treatment of this category of patients: laparoscopic common bile duct exploration (LCBDE), laparoendoscopic rendezvous method (LERV) and one-stage LC( laparoscopic cholecystectomy) after ERCP( endoscopic retrograde cholangiopancreatography). The aim of this prospective study is to evaluate the efficacy and safety Laparoendoscopic rendezvous for difficult cholecystocholedocholithiasis.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-06-04; most recent amendment 2025-06-16.
Status change: Not Yet Recruiting → Recruiting 2025-06-14
Trial Details
NCT Number NCT07008170
Lead Sponsor Minia University
Conditions Gall Stone, Common Bile Duct Calculi, Cholecystitis, Chronic, Choledocholithiasis, Periampullary Diverticula
Enrollment 80 participants
Start Date 2025-06-15
Primary Completion 2026-06-15 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2025-06-19